Mortgage Blog Why this UC Berkeley gene therapy spinout is targeting a $100 million IPO firststargroup October 3, 2019 The Emeryville company says it has improved on the traditional way of delivering corrected copies of genes.
The Emeryville company says it has improved on the traditional way of delivering corrected copies of genes.
